Sulfasalazine in pregnancy to change stress hormone levels
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This Phase 2 study tests whether sulfasalazine, a medicine taken by mouth, can lower a pregnancy stress hormone called CRH in pregnant people. It’s aimed at people at higher risk for preterm birth, to see if the hormone change might be helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You must be pregnant with one baby (singleton pregnancy)
- You must be between 12 and 22 weeks pregnant
- You must have had a preterm birth in a previous pregnancy
- Your pregnancy due dates must be confirmed by ultrasound
- You must be able and willing to swallow the study capsules as instructed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how stress shows up in the body during early pregnancy and whether it’s linked to preterm birth (birth before 37 weeks). You may be asked about your stress and health to help researchers understand who is at higher risk.
This study looks at how corticosteroids (medicines given to help a baby's lungs mature) move through the mother's body and affect the baby during pregnancy. It aims to find the best dose and timing for mothers at risk of preterm birth.
This Phase 2 study tests whether starting low-dose aspirin after delivery can help people who had severe preeclampsia. The goal is to see if this treatment is safe and beneficial in the weeks after birth.
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
This trial tests a behavior-change program to help pregnant women and their partners reduce exposure to hormone-disrupting chemicals. It aims to lower these chemicals in the body and improve health for mother and baby.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.